Background: The aim of the study was to analyse the trend in maternal mortality ratio in a tertiary care centre.Methods: This was a four-year retrospective analysis of maternal deaths that occurred at Government Rajaji Hospital, Department of Obstetrics and Gynaecology, Madurai from January 2017 to December 2020. Cases were stratified based on cause of death. Epidemiological data was collected from the hospital register.Results: The total number of maternal deaths at GRH during the study period is 228, in which death due to obstetric cause was 82 (36%) and non-obstetric cause was 146 (64%). The most common cause in each year was PIH (23%-2017, 29%- 2018), heart disease (22%- 2019) and infection (46%- 2020).Conclusions: We concluded by this study that the maternal death due to non-obstetric causes were more than the obstetric causes due to improved antenatal, post-natal care, institutionalized deliveries and timely referral to the CEmONC (comprehensive emergency obstetric and new-born care) centres and management.
Twin molar pregnancy with a coexisting live fetus and a hydatidiform mole is a rare form of the gestational trophoblastic disease associated with increased risk of obstetrical complications and poor perinatal outcome. Prenatal diagnosis is essential for couple counselling and follow-up in tertiary care centers. The incidence ranges from 1 in 20,000 to 1 in 1,00,000 pregnancies. Management of such cases is tough because the possibility of fetal survival should be weighed against the risk of complications of molar pregnancy. A case of twin molar pregnancy and a coexisting live fetus diagnosed at 15 weeks using ultrasound is described from obstetrical management to a post molar follow-up.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.